News from the healthcare data industry
November 11, 2021 COTA Team New hire joins COTA following seven year tenure at FDA COTA, Inc., an oncology real-world data and analytics company, today announced that a new strategic hire...
SAN FRANCISCO, Nov. 10, 2021 /PRNewswire/ — Datavant, the leader in helping healthcare organizations securely connect their data, today announced the launch of Privacy Hub to raise the bar for patient privacy...
TUESDAY NOVEMBER 9TH, 2021 Amongst vaccinated Americans, Moderna recipients experience most adverse events and Johnson & Johnson recipients have most hospitalizations REDMOND, Wash. – November 9, 2021 – Truveta, the...
CAMBRIDGE, Mass. and DURHAM, N.C., Nov. 9, 2021 /PRNewswire/ — ConcertAI, LLC (ConcertAI), a leader in enterprise AI and RWD solutions for life science companies and healthcare providers, announced today the integration of TeraRecon as...
Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, and Tempus, a leader in artificial intelligence and precision medicine, today announced a...
Tempus Labs Inc., a precision medicine startup led by a Groupon Inc. co-founder, is exploring a U.S. initial public offering, according to people with knowledge of the matter. The Chicago-based company is...
DEVON, Penn., Nov. 2, 2021 — COEUS Holdings and its subsidiaries, together a leading health outcomes, contracting and commercial insights consulting firm, today announced a strategic partnership with Datavant, the leader in privacy-compliant...
SAN FRANCISCO and SAN DIEGO, Nov. 01, 2021 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small molecule kinase...
Cambridge, MA, November 1, 2021 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced that Jeffrey Brown, PhD, is joining...
DUBLIN, Ohio, Oct. 28, 2021 /PRNewswire/ — Cardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE)...